Business · 20/11/2012
FDA Releases Draft Guidance for IRB Responsibilities in Clinical Investigations
The FDA has made available a draft guidance document to help IRBs, clinical investigators, and sponsors ensure the protection of human subjects in clinical trials by reviewing investigator qualifications, research site adequacy, and IND/IDE requirements.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →